These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6119638)

  • 1. Substituted benzamide drugs as selective neuroleptic agents.
    Jenner P; Marsden CD
    Neuropharmacology; 1981 Dec; 20(12B):1285-93. PubMed ID: 6119638
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
    Gnegy ME; Bernabei A; Treisman G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugs.
    Jenner P; Marsden CD
    Acta Psychiatr Scand Suppl; 1984; 311():109-23. PubMed ID: 6142587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of substituted benzamides in biochemical models of dopamine receptors.
    Kebabian JW; Tsuruta K; Cote TE; Grewe CW
    Adv Biochem Psychopharmacol; 1982; 35():17-49. PubMed ID: 6293277
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
    Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
    Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
    Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
    J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemistry and pharmacology of benzamides].
    Boyer P
    Sem Hop; 1983 Mar; 59(12):832-5. PubMed ID: 6306780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The substituted benzamides--a novel class of dopamine antagonists.
    Jenner P; Marsden CD
    Life Sci; 1979 Aug; 25(6):479-85. PubMed ID: 40086
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific receptors for substituted benzamide drugs in brain.
    Jenner P; Theodorou A; Marsden CD
    Adv Biochem Psychopharmacol; 1982; 35():109-41. PubMed ID: 6756059
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
    [No Abstract]   [Full Text] [Related]  

  • 12. How do antipsychotic drugs work?
    Iversen LL
    Neurosci Res Program Bull; 1975 Aug; 13 Suppl():29-51. PubMed ID: 241033
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
    Arushanian EB
    Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors.
    Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF
    Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of multiple receptors for dopamine.
    Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential antagonism of postsynaptic (DA1) and presynaptic (DA2) peripheral dopamine receptors by substituted benzamides.
    Kohli JD; Glock D; Goldberg LI
    Adv Biochem Psychopharmacol; 1982; 35():97-108. PubMed ID: 6756064
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of benzamide drugs on prolactin secretion: relation to the dopamine receptor.
    Meltzer HY; So R; Fang VS
    Adv Biochem Psychopharmacol; 1982; 35():61-82. PubMed ID: 6756062
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
    Lau YS; Runice C; Dowd F
    J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective dopamine D-2 receptor antagonists with an atypical neuroleptic profile.
    Ogren SO
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():462A-463A. PubMed ID: 1354051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.